Lohocla Research to Present at 2021 BIO

Lohocla Research announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled June 10-11 & 14-18, 2021.

Jim Finster, COO will present the Lohocla’s first-of-its-kind, non-opioid pharmaceutical for the treatment of chronic pain. The presentation will be available to registered attendees at 9 am ET June 10.

Attendees at BIO Digital will be able to view Lohocla’s Company Presentation before live meetings in the BIO One-on-One Partnering™ system begin on June 14. To meet with us at BIO Digital, you can find registration information here.

About Lohocla Research
At Lohocla Research Corporation, we work towards one goal: developing products that improve people’s lives. Understanding the challenges of chronic pain and addiction, we focus on transforming the lives of patients suffering from these conditions. Built upon a rationally designed, proprietary molecular platform, we have developed a first-of-its-kind molecule that selectively modulates a discrete set of receptors involved in the chronic-pain signal pathway in overactive peripheral nerves.

About BIO
BIO is the world’s largest advocacy organization representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. Subscribe to Good Day BIO.

Find out more in the Lohocla Research press release.

Categories: Ecosystem News